Cambridge, MA
SURGE seeks to dramatically improve cancer patient survival by disrupting how, when, and where cancer immunotherapy is deployed -- focusing 100% of the effective dose at the right place and at the right time.
surgetx.comThese are collections SURGE Therapeutics is a part of. Click on the collection name to view similar companies.
Series B
$32,000,000
Series A
$26,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on SURGE Therapeutics.